Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells

Oncogene

Volumn 25, Issue 44, 2006, Pages 6003-6014

  Manuvakhova, M ^a,b   Thottassery, J V ^a,b   Hays, S ^a   Qu, Z ^a,b   Rentz, S S ^a   Westbrook, L ^a   Kern, F G ^a,b,c  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

Antiestrogen resistance; Breast cancer; FGF; Signal transduction; SNT 1 PTB domain

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTIESTROGEN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR; FULVESTRANT; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; RAPAMYCIN; RAS PROTEIN; SOS PROTEIN; SUC1 ASSOCIATED NEUROTROPHIC FACTOR INDUCED TYROSINE PHOSPHORYLATED TARGET; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DOXYCYCLINE; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ESTROGEN RECEPTOR MODULATORS; FEMALE; FIBROBLAST GROWTH FACTOR 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOTYROSINE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 33749189548     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209592     Document Type: Article

References (59)

1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, cohen P et al. (1996). EMBO J 15: 6541-6551.
2. Bell AC, West AG, Felsenfeld G. (2001). Science 291: 447-450.
3. Califano D, Rizzo C, D'Alessio A, Colucci-D'Amato GL, Cali G, Bartoli PC et al. (2000). J Biol Chem 275: 19297-19305.
4. Cheatham L, Monfar M, Chou MM, Blenis J. (1995). Proc Natl Acad Sci USA 92: 11696-11700.
5. Dennis PB, Pullen N, Pearson RB, Kozma SC, Thomas G. (1998). J Biol Chem 273: 14845-14852.
6. Dhalluin C, Yan K, Plotnikova O, Lee KW, Zeng L, Kuti M et al. (2000). Mol Cell 6: 921-929.
7. Dunican DJ, Williams EJ, Howell FV, Doherty P. (2001). Cell Growth Differ 12: 255-264.
8. Ehrhard KN, Jacoby JJ, Fu XY, Jahn R, Dohlman HG. (2000). Nat Biotechnol 18: 1075-1079.
9. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS et al. (1998). J Biol Chem. 273: 18623-18632.
10. Ferrari S, Bannwarth W, Morley SJ, Totty NF, Thomas G. (1992). Proc Natl Acad Sci USA 89: 7282-7286.
11. Fingar DC, Blenis J. (2004). Oncogene 23: 3151-3171.
12. Gonzalez-Garcia A, Garrido E, Hernandez C, Alvarez B, Jimenez C, Cantrell DA et al. (2002). J Biol Chem 277: 1500-1508.
13. Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J. (2001). Proc Natl Acad Sci USA 98: 8578-8583.
14. Hadari YR, Kouhara H, Lax I, Schlessinger J. (1998). Mol Cell Biol 18: 3966-3973.
15. Han JW, Pearson RB, Dennis PB, Thomas G. (1995). J Biol Chem 270: 21396-21403.
16. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S et al. (2002). Cell 110: 177-189.
17. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. (2001). Proc Natl Acad Sci USA 98: 9666-9670.
18. Iijima Y, Laser M, Shiraishi H, Willey CD, Sundaravadivel B, Xu L et al. (2002). J Biol Chem 277: 23065-23075.
19. Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhonen S et al. (1993). Int J Cancer 54: 378-382.
20. Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H et al. (2003). Mol Cell 11: 895-904.
21. Kimpinski K, Mearow K. (2001). J Neurosci Res 63: 486-499.
22. Klint P, Kanda S, Claesson-Welsh L. (1995). J Biol Chem 270: 23337-23344.
23. Klint P, Kanda S, Kloog Y, Claesson-Welsh L. (1999). Oncogene 18: 3354-3364.
24. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I et al. (1997). Cell 89: 693-702.
25. Koziczak M, Holbro T, Hynes NE. (2004). Oncogene 23: 3501-3508.
26. Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG. (1993). Cancer Res 53: 2178-2187.
27. Kurokawa K, Iwashita T, Murakami H, Hayashi H, Kawai K, Takahashi M. (2001). Oncogene 20: 1929-1938.
28. Lamothe B, Yamada M, Schaeper U, Birchmeier W, Lax I, Schlessinger J. (2004). Mol Cell Biol 24: 5657-5666.
29. Lax I, Wong A, Lamothe B, Lee A, Frost A, Hawes J et al. (2002). Mol Cell 10: 709-719.
30. Manning BD, Cantley LC. (2003). Trends Biochem Sci 28: 573-576.
31. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB et al. (1993). Cancer Res 53: 2168-2177.
32. McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S et al. (1998). Clin Cancer Res 4: 697-711.
33. McLeskey SW, Zhang L, Kharbanda S, Kurebayashi J, Lippman ME, Dickson RB et al. (1996). Breast Cancer Res Treat 39: 103-117.
34. Meakin SO, MacDonald JI, Gryz EA, Kubu CJ, Verdi JM. (1999). J Biol Chem 274: 9861-9870.
35. Moffa AB, Tannheimer SL, Ethier SP. (2004). Mol Cancer Res 2: 643-652.
36. Ong SH, Goh KC, Lim YP, Low BC, Klint P, Claesson-Welsh L et al. (1996). Biochem Biophys Res Commun 225: 1021-1026.
37. Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Schlessinger J et al. (2000). Mol Cell Biol 20: 979-989.
38. Ong SH, Hadari YR, Gotoh N, Guy GR, Schlessinger J, Lax I. (2001). Proc Natl Acad Sci USA 98: 6074-6079.
39. Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J et al. (1995). Int J Cancer 61: 170-176.
40. Price DJ, Mukhopadhyay NK, Avruch J. (1991). J Biol Chem 266: 16281-16284.
41. Qu Z, Thottassery JV, Van Ginkel S, Manuvakhova M, Westbrook L, Roland-Lazenby C et al. (2004). Gene 327: 61-73.
42. Rabin SJ, Cleghon V, Kaplan DR. (1993). Mol Cell Biol 13: 2203-2213.
43. Romanelli A, Dreisbach VC, Blenis J. (2002). J Biol Chem 277: 40281-40289.
44. Romanelli A, Martin KA, Toker A, Blenis J. (1999). Mol Cell Biol 19: 2921-2928.
45. Stoletov KV, Ratcliffe KE, Terman BI. (2002). FASEB J 16: 1283-1285.
46. Tsoulfas P, Stephens RM, Kaplan DR, Parada LF. (1996). J Biol Chem 271: 5691-5697.
47. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. (2000). Proc Natl Acad Sci USA 97: 7963-7968.
48. Wang F. (2002). In Vitro Cell Dev Biol Anim 38: 178-183.
49. Wang J-K, Xu H, Li H-C, Goldfarb M. (1996). Oncogene 13: 721-729.
50. Wu Y, Chen Z, Ullrich A. (2003). Biol Chem 384: 1215-1226.
51. Xie WQ, Rothblum LI. (1991). Biotechniques 11: 324 326-324, 327.
52. Xu H, Goldfarb M. (2001). J Biol Chem 276: 13049-13056.
53. Xu H, Lee KW, Goldfarb M. (1998). J Biol Chem 273: 17987-17990.
54. Yonezawa K, Tokunaga C, Oshiro N, Yoshino K. (2004). Biochem Biophys Res Commun 313: 437-441.
55. Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, Kondo M et al. (1998). Clin Immunol Immunopathol 89: 28-34.
56. Yuen EC, Mobley WC. (1999). Exp Neurol 159: 297-308.
57. Zhang L, Kharbanda S, Chen D, Bullocks J, Miller DL, Ding IYF et al. (1997). Oncogene 15: 2093-2108.
58. Zhang Y, Dong Z, Nomura M, Zhong S, Chen N, Bode AM et al. (2001). J Biol Chem 276: 20913-20923.
59. Zhang Y, Lin Y, Bowles C, Wang F. (2004). J Biol Chem 279: 55348-55354.